Tarsus Pharmaceuticals is expanding its pipeline to target meibomian gland disease and rosacea, with promising Phase 2 ...

Beyond MariTide, Amgen has a rich pipeline with more than 30 phase 3 programs. Some are for existing medicines seeking label ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

According to US secondary stroke prevention guidelines, patients with ESUS should not be treated with anticoagulants or ...

The surge in global cancer cases is raising serious concerns among experts. A recent study published in Monday in Cancer, a ...

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

“I’m right in the mix,” claimed McIlroy, the world number three, after posting a second round 68 – five birdies and one lone ...

This Comment is linked to The Lancet Haematology Series on Sexual Health in Patients with Haematological Malignancies; we ...

In an interview with Targeted Oncology, Mark R. Litzow, MD, discussed the incorporation of Immunotherapy into upfront acute ...

Tourism Northern Ireland has described the recent Amgen Irish Open in Co Down as “incredibly successful”. More than 71,000 ...

Bob MacIntyre reckoned it was a case of “robbery” as he shot the “best two-under-par round of my life” to be in the mix along ...

Since an initial FDA go-ahead in 2020, Sanofi’s Sarclisa has been specifically approved for patients with previously treated ...